Oral administration of 1,25-dihydroxyvitamin D3 completely protects NOD mice from insulin-dependent diabetes mellitus
- 23 July 2003
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 417 (1) , 77-80
- https://doi.org/10.1016/s0003-9861(03)00338-2
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- 1,25-Dihydroxycholecalciferol Prevents and Ameliorates Symptoms of Experimental Murine Inflammatory Bowel DiseaseJournal of Nutrition, 2000
- Current Understanding of the Molecular Actions of Vitamin DPhysiological Reviews, 1998
- 1,25-Dihydroxycholecalciferol Inhibits the Progression of Arthritis in Murine Models of Human Arthritis ,Journal of Nutrition, 1998
- The Vitamin D Receptor--Structure and Transcriptional ActivationExperimental Biology and Medicine, 1997
- 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis.Proceedings of the National Academy of Sciences, 1996
- Vitamin DNutrition Today, 1993
- 1,25-Dihydroxyvitamin D 3 Attenuates of Expression of Experimental Murine Lupus of MRL/1 MiceAutoimmunity, 1992
- SPECIFIC HIGH-AFFINITY RECEPTORS FOR 1,25-DIHYDROXYVITAMIN D3IN HUMAN PERIPHERAL BLOOD MONONUCLEAR CELLS: PRESENCE IN MONOCYTES AND INDUCTION IN T LYMPHOCYTES FOLLOWING ACTIVATIONJournal of Clinical Endocrinology & Metabolism, 1983
- 1,25-Dihydroxyvitamin D 3 Receptors in Human LeukocytesScience, 1983
- Biological Activity of 25-Hydroxyergocalciferol in RatsJournal of Nutrition, 1970